1 |
BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A cancer journal for clinicians, 2024, 74(3): 229-263.
|
2 |
姚一菲, 孙可欣, 郑荣寿. 《2022全球癌症统计报告》解读:中国与全球对比[J]. 中国普外基础与临床杂志, 2024, 31(7): 769-780.
|
3 |
吴杨凡, 刘明, 赵波, 等. 乳腺癌患者发生静脉血栓栓塞症诊疗过程和风险评估相关研究新进展[J]. 河北医学, 2020, 26(12): 2103-2106.
|
4 |
刘英超. 晚期恶性肿瘤患者凝血功能指标检测的临床意义[J]. 实用检验医师杂志, 2022, 14(1): 9-12.
|
5 |
LEI Z, GUO D. Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer[J]. Blood coagulation and fibrinolysis, 2021, 32(8): 572-577.
|
6 |
颜丙芳, 夏兰兰, 孟玮. 乳腺癌患者血浆凝血四项水平的变化及临床意义[J]. 滨州医学院学报, 2021, 44(4): 270-271, 274.
|
7 |
中华人民共和国国家卫生健康委员会. 乳腺癌诊疗指南(2022年版)[EB/OL]. (2022-04-11)[2025-05-12].
|
8 |
张少华, 王晓稼, 江泽飞. 乳腺癌内分泌治疗专家共识(2023版)[J]. 中华医学杂志, 2023, 103(38): 2993-3001.
|
9 |
李凡, 任国胜. 乳腺癌诊治现状与展望[J]. 中国普外基础与临床杂志, 2019, 26(12): 1393-1397.
|
10 |
庞宏欣, 王卫, 李艳红. 乳腺癌术后内分泌治疗药物的应用研究进展[J]. 中国处方药, 2022, 20(10): 189-191.
|
11 |
BLONDON M, BODMER A, THOUVENIN L, et al. Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: The prospective HEMOBREAST cohort[J]. Blood advances, 2022, 6(9): 2884-2892.
|
12 |
戴庆雪, 钟小芬. 不同TNM分期恶性肿瘤患者凝血功能、NLR检测及其临床意义[J]. 浙江创伤外科, 2024, 29(4): 701-703.
|
13 |
彭超, 全建峰. 凝血主要因素与恶性肿瘤相关性的研究进展[J]. 中国临床研究, 2021, 34(2): 243-247.
|
14 |
袁宝斌, 王俊, 李厚怀, 等. 胸腔镜辅助超声刀切除术治疗食管癌效果及对患者创伤程度、凝血功能及肺功能的影响[J]. 临床和实验医学杂志, 2021, 20(16): 1733-1738.
|
15 |
DIRIX L Y, OEYEN S, BUYS A, et al. Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer[J]. Breast cancer research and treatment, 2022, 192(3): 583-591.
|
16 |
胡永伟, 白永颖, 张靖华. 乳腺癌患者血浆凝血参数的变化及临床意义[J]. 医学信息, 2023, 36(4): 113-117.
|
17 |
魏巍, 王华, 孙颖. 乳腺癌患者凝血四项、D-D水平与临床病理特征的相关性[J]. 临床医学, 2022, 42(11): 21-23.
|
18 |
CRONIN-FENTON D P, SØNDERGAARD F, PEDERSEN L A, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997-2006[J]. British journal of cancer, 2010, 103(7): 947-953.
|
19 |
WALKER A J, CARD T R, WEST J, et al. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases[J]. European journal of cancer, 2013, 49(6): 1404-1413.
|
20 |
FALANGA A, MARCHETTI M. Hemostatic biomarkers in cancer progression[J]. Thrombosis research, 2018, 164 Suppl 1: S54-S61.
|
21 |
HOTOLEANU C. Association between obesity and venous thromboembolism[J]. Medicine and pharmacy reports, 2020, 93(2): 162-168.
|
22 |
王德光, 王洪燕, 谭春玲, 等. 乳腺癌患者发生静脉血栓栓塞症危险因素分析[J]. 创伤与急危重病医学, 2021, 9(2): 116-119.
|
23 |
KAPOOR E, KLING J M, LOBO A S, et al. Menopausal hormone therapy in women with medical conditions[J]. Best practice & research. Clinical endocrinology & metabolism, 2021, 35(6): 101578.
|
24 |
SUN J, HAN K, XU M, et al. Blood viscosity in subjects with type 2 diabetes mellitus: Roles of hyperglycemia and elevated plasma fibrinogen[J]. Frontiers in physiology, 2022, 13: 827428.
|
25 |
刘秋颖, 陈锋, 崔婵娟, 等. 恶性肿瘤患者出现单纯凝血酶时间明显延长的原因探讨[J]. 检验医学, 2018, 33(10): 967-968.
|
26 |
HAN X, SONG X, XIAO Z, et al. Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment[J]. Frontiers in cell and developmental biology, 2024, 12: 1310442.
|
27 |
LI S, LI L, LIN X, et al. Targeted inhibition of tumor inflammation and tumor-platelet crosstalk by nanoparticle-mediated drug delivery mitigates cancer metastasis[J]. American chemical society nano, 2022, 16(1): 50-67.
|
28 |
LAL I, DITTUS K, HOLMES C E. Platelets, coagulation and fibrinolysis in breast cancer progression[J]. Breast cancer research, 2013, 15(4): 207.
|
29 |
XU X R, ZHANG D, OSWALD B E, et al. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond[J]. Critical reviews in clinical laboratory sciences, 2016, 53(6): 409-430.
|
30 |
SCHLESINGER M. Role of platelets and platelet receptors in cancer metastasis[J]. Journal of hematology & oncology, 2018, 11(1): 125.
|
31 |
黄冬琴, 覃韬, 谢显龙, 等. 脓毒症院内死亡与肝功能的关系及危险因素分析[J]. 广东医学, 2018, 39(5): 725-729.
|
32 |
LI X, LI Z, LI L, et al. Toremifene, an alternative adjuvant endocrine therapy, is better than tamoxifen in breast cancer patients with CYP2D6*10 mutant genotypes[J]. Cancer research and treatment, 2024, 56(1): 134-142.
|
33 |
SALVAGNO G L, SANCHIS-GOMAR F, PICANZA A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications[J]. Critical reviews in clinical laboratory sciences, 2015, 52(2): 86-105.
|
34 |
DEMIRKOL S, BALTA S, CAKAR M, et al. Red cell distribution width: A novel inflammatory marker in clinical practice[J]. Cardiology journal, 2013, 20(2): 209.
|
35 |
时慧, 赵邵林, 王加平. 血红蛋白与红细胞分布宽度比值对胃癌患者预后的预测价值[J]. 国际检验医学杂志, 2022, 43(19): 2421-2425.
|
36 |
LEE H S, JUNG E J, KIM J M, et al. The usefulness of red blood cell distribution width and its ratio with platelet count in breast cancer after surgery and adjuvant treatment: A retrospective study[J]. Gland surgery, 2022, 11(12): 1864-1873.
|
37 |
BAMBACE N M, HOLMES C E. The platelet contribution to cancer progression[J]. Journal of thrombosis and haemostasis, 2011, 9(2): 237-249.
|
38 |
季为军. 抗凝治疗对中晚期胃癌改善高凝状态,抗肿瘤转移的临床研究[J]. 世界复合医学, 2021, 7(12): 17-19, 23.
|